ASPIRE Program Participating in New Research Study to Develop Blood Test for Early Autism Diagnosis

The purpose of this research study is to develop an algorithm to classify blood RNA gene expression patterns in such a way as to maximize agreement between the classification and a clinical assessment of the presence or absence of Autism Spectrum Disorder.

ASPIRE Program Participating in New Research Study to Develop Blood Test for Early Autism Diagnosis click to enlarge Dr. Linmarie Sikich, second from left, bottom row, and the ASPIRE Team

In addition, this study hopes to assess the clinical sensitivity and specificity of the blood RNA gene expression classification algorithm (the SDX-002 test) in children referred to a developmental evaluation clinic for a possible developmental disorder. Participants must not have had a prior diagnosis of autism spectrum disorder. Participants will complete a diagnostic evaluation and language assessments, and a blood sample will be taken for analysis. There are no treatments involved in this study. This study is sponsored by the SynapDx Corporation.

Research-related services will be provided free of charge, and participants will be compensated $75 per visit.

For more information, please contact Lindsey Hazzard, LCSW at 1-800-708-0048 or by email at ASPIRE@unc.edu.

Also, check out the ASPIRE Program Website at http://www.med.unc.edu/psych/aspire to find out about our other research opportunities.